Drug Traceability Scanner Market Trends: the global market size is projected to reach USD 0.51 billion by 2031

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Drug Traceability Scanner- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Drug Traceability Scanner market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Drug Traceability Scanner was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 514 million by 2031 with a CAGR of 8.4% during the forecast period 2025-2031.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4786769/drug-traceability-scanner



Product Introduction: Drug Traceability Scanner

A Drug Traceability Scanner is a specialized, intelligent device engineered to safeguard the pharmaceutical supply chain. It integrates advanced optical recognition, real-time data processing, and secure network communication to read and decode standardized traceability marks (such as GS1-compliant 1D/2D barcodes or RFID tags) on drug packaging.

By instantly parsing critical data-including production batch number, expiration date, manufacturer, and full circulation history-it enables complete visibility and supervision from production and warehousing to distribution and final sale. The scanner is a vital tool for ensuring drug safety, combating counterfeit medicines, and fulfilling stringent global regulatory requirements.

Core Value Proposition

Ensures Drug Safety & Authenticity: Provides immediate verification of drug legitimacy, blocking counterfeit and substandard products from reaching patients.

Full-Chain Visibility: Enables end-to-end tracking and tracing, allowing for rapid identification of product history and swift, targeted recalls when necessary.

Regulatory Compliance: Designed to meet and facilitate compliance with major global regulations (e.g., China's Drug Traceability Management Measures, EU FMD, U.S. DSCSA).

Operational Efficiency: Automates data capture, streamlines inventory management, and reduces manual errors in pharmacies, hospitals, and distribution centers.

Key Market Insights & Forecast

The global market for Drug Traceability Scanners is on a strong growth trajectory, driven by worldwide regulatory mandates and digital transformation in healthcare.

The market is projected to reach approximately USD 0.51 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 8.4%.

Manufacturing is concentrated in East Asia, leveraging robust electronics supply chains and cost-effective production capabilities.

Leading global manufacturers include Soman Technology, Tiga Healthcare Technologies, iData, Urovo, and Rakinda, among others.

Industry Chain Analysis

Upstream: Relies on suppliers of high-precision scanning modules, embedded electronic components, communication chips (4G/5G/Wi-Fi), and durable, industry-grade materials.

Midstream: Comprises equipment manufacturers who assemble, program with compliant firmware, and rigorously test scanners for accuracy, durability, and data security before distribution.

Downstream: Serves key end-users:

Pharmaceutical Companies: For production line serialization, warehouse logistics, and regulatory reporting.

Pharmacies & Hospitals: For inventory management, sales verification, authenticity checks, and compliance data submission.

Regulatory Bodies: For market surveillance and enforcement activities.

Critical Industry Trends

Multi-Technology Integration: Scanners now combine 2D, QR, RFID, and NFC reading to handle diverse global standards and packaging types (e.g., blister packs, cold-chain labels).

AI-Enhanced Intelligence: Embedded algorithms automate counterfeit detection, batch reconciliation, and alerts for expired or recalled drugs, reducing manual compliance work.

Edge Computing & Robust Connectivity: Advanced local data processing (edge computing) with extended offline storage ensures reliable operation in low-network areas, with automatic sync upon reconnection.

Specialized Environmental Adaptation: Scanners are being ruggedized for specific conditions, such as cold-chain environments (-20°C to 5°C), dusty warehouses (IP65+ rating), and high-handling logistics hubs.

Significant Growth Opportunities

Rural & Remote Market Expansion: Growing demand from underpenetrated rural pharmacies in emerging economies, fueled by policy mandates and healthcare infrastructure funding.

Cold-Chain Specialization: Rising need for scanners built to track high-value biologics and vaccines, featuring low-temperature operation and integration with temperature monitoring systems.

Pharmacy Digital Integration: Demand for scanners that seamlessly integrate with retail pharmacy digital ecosystems (POS, inventory systems) to automate workflows.

Global Market Penetration: Opportunity to supply "multi-compliant" scanner models that meet the varying standards of the EU, U.S., China, and other regulated markets.

Primary Industry Challenges

Fragmented Global Standards: Complying with different regional regulations and code standards increases R&D complexity and cost for manufacturers.

Cost Sensitivity: High prices for advanced scanners can be a barrier for small pharmacies and distributors in cost-sensitive markets.

Complex Packaging & Environments: Achieving high recognition accuracy across varied, damaged, or challenging packaging (glossy, frosted, wrinkled) in harsh conditions requires ongoing technical refinement.

Data Security & System Interoperability: Ensuring encrypted, secure data transmission while maintaining seamless connectivity between disparate national platforms, corporate ERPs, and retail systems remains a technical hurdle.

Conclusion

The Drug Traceability Scanner is more than a simple data capture tool; it is a foundational component of modern, secure, and transparent pharmaceutical supply chains worldwide. As regulations tighten and digitalization accelerates, its role in protecting patient safety and ensuring supply chain integrity will only become more critical, driving continuous innovation and adoption across the globe.



The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Drug Traceability Scanner market is segmented as below:
By Company
Soman Technology
Tiga Healthcare Technologies
iData
Urovo
ivysun
Rakinda
XTIOT
newland
Seuic
Xincode
Superlead
Dingyu Iot
Xindeli Tech
Deli

Segment by Type
Stationary Scanner
Handheld Scanner

Segment by Application
Pharmaceutical Companies
Hospitals Pharmacies
Pharmacies
Others

Each chapter of the report provides detailed information for readers to further understand the Drug Traceability Scanner market:

Chapter 1: Introduces the report scope of the Drug Traceability Scanner report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Drug Traceability Scanner manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Drug Traceability Scanner market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Drug Traceability Scanner in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Drug Traceability Scanner in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Drug Traceability Scanner competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Drug Traceability Scanner comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Drug Traceability Scanner market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Drug Traceability Scanner Market Research Report 2025
Global Drug Traceability Scanner Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Drug Traceability Scanner Market Insights, Forecast to 2031

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

This release was published on openPR.